Monday, October 08, 2018 3:22:50 PM
I believe there is approx. 10-12 mil shares outstanding right now with Novartis owning 2.6mil shares and other institutional investors owning approx. 5mil shares. That's approx. 58-70% institutional ownership. That's a lot. And that's good. IMO, these institutions would not plunk down $12mil dollars if they were not sure this flu vaccine is not legit.
Next, I believe ALT is worried about a hostile takeover by Novartis. Prior to todays offering, Novartis owned 35-48% of the outstanding shares. With a few million more shares purchased on the open market, Novartis could own over 51% of the company. This new offering has changed that.
And finally, this new placement give ALT approx. $45mil in cash on hand. That is a lot of working capital to start production of its nasal spray. In other words they could be going this alone.
12mil outstanding shares is still a very low float, especially considering the Institutional ownership. Do I wish I sold this morning in the pre-market....yes I could have doubled my share count by buying back in and took my gf out for a very nice dinner. But I didn't :( but im not selling.....Im going to wait and see how this all plays out.
Cheers
Chenzo
Recent ALT News
- Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Altimmune to Participate at Two Upcoming Conferences • GlobeNewswire Inc. • 05/01/2024 11:30:00 AM
- Altimmune Statement on the Passing of Dr. Stephen Harrison • GlobeNewswire Inc. • 04/25/2024 09:24:52 PM
- Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- U.S. Stock Index Futures Point to a Rebound, Oil See Declines in Early Trading • IH Market News • 03/27/2024 10:57:08 AM
- Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024 • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 05:04:25 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:37:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:02:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:01:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:00:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:03:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:02:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:01:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 11:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:32:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:31:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 11:30:13 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/26/2024 04:49:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 11:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 11:00:20 PM
- Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024 • GlobeNewswire Inc. • 01/02/2024 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM